Trials that use: Covariate adjustment
4,539 results
- ENVISIONIndependent statistical analysis of A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENVISIONIndependent statistical analysis of A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EPICIndependent statistical analysis of Mechanisms of EPO-induced Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03810911).
- Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Epidemiology of Depression, Anxiety, and Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology of Depression, Anxiety, and Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717041).
- Epiduo Pediatric Acne Study: Complete Statistical AnalysisIndependent statistical analysis of Epiduo Pediatric Acne Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138735).
- Epidural Neostigmine for Labor Pain: Complete Statistical AnalysisIndependent statistical analysis of Epidural Neostigmine for Labor Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00779467).
- Epidural Neuroplasty for the Treatment of Herniated Lumbar Disk: Complete Statistical AnalysisIndependent statistical analysis of Epidural Neuroplasty for the Treatment of Herniated Lumbar Disk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03101033).
- Epigenetic Regulation of BDNF in Major Depression: Complete Statistical AnalysisIndependent statistical analysis of Epigenetic Regulation of BDNF in Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182103).
- EPOCHIndependent statistical analysis of An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EPT and MSMIndependent statistical analysis of Expedited Partner Therapy and the HIV Prevention Cascade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04553211).
- EQUIPED-ADRDIndependent statistical analysis of Enhanced Quality in Primary Care for Elders With Diabetes and Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EQUIPPEDIndependent statistical analysis of Efficiency And Quality In Post-Surgical Pain Therapy After Discharge: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05221866).
- Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon: Complete Statistical AnalysisIndependent statistical analysis of Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ERA-PAHIndependent statistical analysis of Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02911844).
- ERECTIndependent statistical analysis of Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Erector Spinae Plane vs. Paravertebral Nerve Block for Thoracic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Erector Spinae Plane vs. Paravertebral Nerve Block for Thoracic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03758261).
- EREPIndependent statistical analysis of Emotion Regulation and Emotion Perception: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03790878).
- ERGO2Independent statistical analysis of Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ertugliflozin: Cardioprotective Effects on Epicardial Fat: Complete Statistical AnalysisIndependent statistical analysis of Ertugliflozin: Cardioprotective Effects on Epicardial Fat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04167761).
- EscapeIndependent statistical analysis of Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ESCAPEIndependent statistical analysis of Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ESCAPeIndependent statistical analysis of Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01283009).
- ESCAPEDIndependent statistical analysis of Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Escitalopram Effects on CSF Amyloid Beta: Complete Statistical AnalysisIndependent statistical analysis of Escitalopram Effects on CSF Amyloid Beta: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02161458).
- ESETTIndependent statistical analysis of Established Status Epilepticus Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01960075).
- ESkAPEIndependent statistical analysis of Enhancing Skeletal Adaptations to PTH and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05029128).
- Esmolol for Treatment of Perioperative Tachycardia: Complete Statistical AnalysisIndependent statistical analysis of Esmolol for Treatment of Perioperative Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01208402).
- Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery: Complete Statistical AnalysisIndependent statistical analysis of ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257941).
- Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans: Complete Statistical AnalysisIndependent statistical analysis of Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ESTRELLAIndependent statistical analysis of A Study of Belcesiran in Patients With AATLD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764448).
- Estrogen and Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Estrogen and Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03436992).
- Estrogen Variability and Irritability During the Menopause Transition: Complete Statistical AnalysisIndependent statistical analysis of Estrogen Variability and Irritability During the Menopause Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05388656).
- Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ETDAIndependent statistical analysis of Eustachian Tube Dysfunction Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667301).
- EU RCTIndependent statistical analysis of ILLUMENATE EU Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01858363).
- EURORELAXIndependent statistical analysis of Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04124757).
- EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors: Complete Statistical AnalysisIndependent statistical analysis of EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EVADEComplete statistical analysis of the randomized phase 2/3 EVADE trial of ADG20 for the prevention of COVID-19, including trial design, primary and secondary endpoints, risk differences, hazard ratios, statistical methodology, safety, and…
- Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluate Severe Hepatic Impairment on Dacomitinib PK: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Severe Hepatic Impairment on Dacomitinib PK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03865446).
- Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression: primary endpoint results, effect estimate with confidence…
- Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating Air Leak Detection in Intubated Patients: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Air Leak Detection in Intubated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01857986).